ACC 2009 schedule: Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
Apalmer (talk | contribs)
nocaptcha
14,582 edits
Apalmer (talk | contribs)
nocaptcha
14,582 edits
No edit summary
 
(61 intermediate revisions by 3 users not shown)
Line 2: Line 2:


'''Filming location:''' Rosen Plaza Hotel 9700 International Drive Phone: 407-996-9700
'''Filming location:''' Rosen Plaza Hotel 9700 International Drive Phone: 407-996-9700
 
Filming will occur from Saturday to Tuesday (March 28 - March 31).  Dr. Gibson is available to interview during all times listed '''in black'''.  For all times listed '''<font color="green"> in green</font>''', Dr. Gibson is unavailable to conduct the interview.  As a presenter, you should go ahead and speak about your topic/present your slides.
Filming will occur from Saturday to Tuesday (March 28 - March 31).  Dr. Gibson is available to interview during all times listed '''in black'''.  For all times listed '''<font color="green"> in green</font>''', Dr. Gibson is unavailable to conduct the interview.  As a presenter, you should go ahead and speak about your topic/present your slides.


Line 45: Line 45:


==Sunday March 29, 2009==
==Sunday March 29, 2009==
Presentations will occur throughout the day on Sunday. Dr. Gibson will not be available to interview between 7:00 AM and 8:30 AM, 2:00 to 3:30 PM, and 6:00 PM to 9:30 PM. As a presenter you should go ahead and speak about your topic and present your slides during these times ('''<font color="green">listed in green</font>''').
Presentations will occur throughout the day on Sunday. Dr. Gibson will not be available to interview between 7:00 AM and 11:00 AM, 1:30 PM to 4:00 PM, and 6:00 PM to 9:30 PM. As a presenter you should go ahead and speak about your topic and present your slides during these times ('''<font color="green">listed in green</font>''').


=== <font color="green">8:00 AM</font>===
=== <font color="green">8:00 AM</font>===


=== <font color="green">8:30 AM</font>===
=== <font color="green">8:30 AM</font>===


=== <font color="green">9:00 AM</font>===


===9:00 AM ===
=== <font color="green">9:30 AM</font>===
 
===9:30 AM===
*'''Interviewee:''' Davy Cheng
*'''Confirmed (Y/N):''' Y
*'''Trial:''' Endovascular Versus Open Surgical Repair of Thoracic Aortic Disease: A Meta-regression Analysis
*'''Phone number:''' 519-859-0219


===10:00 AM ===
=== <font color="green">10:00 AM</font>===


===10:30 AM===
=== <font color="green">10:30 AM</font>===
*'''Interviewee:'''  Ziyad M. Hijazi, M.D., MPH, FSCAI
*'''Confirmed:'''  Y
*'''Topic:'''  SCAI's Structural Heart Disease Council and other SCAI initiatives
*'''On-site phone:'''  773-936-8481


===11:00 AM===
===11:00 AM===
*'''Interviewee:'''  Bonnie H. Weiner, M.D., FSCAI
*'''Confirmed:'''  Y
*'''Topic:'''  TBD
*'''On-site phone:'''  978-501-2158


===11:30 AM===
===11:30 AM===
*'''Interviewee:'''  Andrew J. Boyle, M.D.
*'''Confirmed:'''  Y
*'''Trial:''' The VentrAssist U.S. Pivotal Bridge to Cardiac Transplantation Trial
*'''On-site phone:''' 612-578-9149


===12:00 PM===
===12:00 PM===
*'''Interviewee:'''  Chris Cates
*'''Confirmed:'''  Y
*'''Trial:''' Acute stroke intervention and neuro-rescue


===12:30 PM===
===12:30 PM===


===1:00 PM===
===1:00 PM===
*'''Interviewee:'''  Steven R. Bailey, M.D., FSCAI
*'''Confirmed:'''  Y
*'''Topic:''' TBD
*'''On-site phone:'''  210-416-3175


===1:30 PM===
=== <font color="green">1:30 PM</font>===


=== <font color="green">2:00 PM</font>===
=== <font color="green">2:00 PM</font>===
Line 93: Line 106:


===4:30 PM===
===4:30 PM===
*'''Interviewee:''' Davy Cheng
*'''Confirmed (Y/N):''' Y
*'''Trial:''' Endovascular Versus Open Surgical Repair of Thoracic Aortic Disease: A Meta-regression Analysis
*'''Phone number:''' 519-859-0219


===5:00 PM===
===5:00 PM===
*'''Interviewee:''' Christian Hamm
*'''Interviewee:''' Christian Hamm
*'''Confirmed (Y/N):'''  
*'''Confirmed (Y/N):''' Y
*'''Trial:''' Prehospital Tirofiban in ST-Elevation Myocardial Infarction: One-Year Outcome of ON-TIME-2
*'''Trial:''' Prehospital Tirofiban in ST-Elevation Myocardial Infarction: One-Year Outcome of ON-TIME-2
*'''Phone number:'''  
*'''Phone number:''' + 49 172 69 36 243


''[[ACC 2009 schedule#Click on Date for Detailed Schedule|Return to top]]''
''[[ACC 2009 schedule#Click on Date for Detailed Schedule|Return to top]]''
Line 108: Line 125:


===8:30 AM===
===8:30 AM===
*'''Interviewee:''' David Cohen
*'''Confirmed:''' Y
*'''Trial:''' Health Related Quality of Life and U.S. Based Economic Outcomes of PCI With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel and Left Main Coronary Artery Disease: 1-Year Results From the SYNTAX Trial
*'''On-site phone:''' 617-519-0310


===9:00 AM ===
===9:00 AM ===
*'''Interviewee:''' Mark Creager
*'''Confirmed:''' Y
*'''Trial:''' Treatment of Intermittent Claudication With Hypoxia-Inducible Factor-1α
*'''On-site phone:'''


===9:30 AM ===
===9:30 AM ===
*'''Interviewee:''' Raimund Erbel
*'''Confirmed:''' Y
*'''Topic:''' Signs of Subclinical Coronary Atherosclerosis Measured as Coronary Artery Calcification Improve Risk Prediction of Hard Events Beyond Traditional Risk Factors in an Unselected General Population: The Heinz Nixdorf Recall Study Five-Year Outcome Data
*'''On-site phone:''' 49 173 283 7339


===10:00 AM ===
===10:00 AM ===
*'''Interviewee:''' Robert Hendel
*'''Confirmed:''' Y
*'''Trial:''' Multicenter Assessment of the Utilization of SPECT Myocardial Perfusion Imaging Using the ACCF Appropriateness Criteria: The ACCF and United HealthCare SPECT Pilot Study
*'''On-site phone:''' 630-310-2162


===10:30 AM ===
===10:30 AM ===
*'''Interviewee:''' Daniel Mark
*'''Confirmed:''' Y
*'''Trial:''' Quality of Life Outcomes With Surgical Ventricular Reconstruction in Symptomatic Heart Failure: Results From the STICH Trial
*'''On-site phone:'''


===11:00 AM===
===11:00 AM===
*'''Interviewee:''' Germano DiSciascio
*'''Confirmed:''' Y
*'''Trial:''' Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention. Preliminary Results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Randomized Trial
*'''On-site phone:''' +39-335-6157260


===11:30 AM===
=== <font color="green">11:30 AM</font>===
*'''Interviewee:'''  Larry S Dean, M.D., FSCAI
*'''Topic:'''  Washington State DES coverage decision OR Washington off-site surgery CON process
*'''Confirmed:'''  Y
*'''On-site phone:'''


=== <font color="green">12:00 PM</font>===
=== <font color="green">12:00 PM</font>===
Line 130: Line 175:


=== <font color="green">2:00 PM</font>===
=== <font color="green">2:00 PM</font>===
'''Interviewee:'''  Mark Turco, MD, FSCAI
'''Confirmed:''' Y
'''Topic:'''  Comparative Effectiveness Research
'''On-site phone:'''  301-938-3485


===2:30 PM===
===2:30 PM===
*'''Interviewee:''' Mark Turco, MD, FSCAI
*'''Confirmed:''' Y
*'''Topic:''' Comparative Effectiveness Research
*'''On-site phone:''' 301-938-3485


===3:00 PM===
===3:15 PM===
*'''Interviewee:''' Tobias Reichlin
*'''Confirmed:''' Y
*'''Topic:''' Incremental Value of Copeptin for Rapid Rule out of Acute Myocardial Infarction
*'''On-site phone:''' 0041 79 755 06 31


===3:30 PM===
=== <font color="green">4:00 PM</font>===
 
===4:00 PM===


=== <font color="green">4:30 PM</font>===
=== <font color="green">4:30 PM</font>===


=== <font color="green">5:00 PM</font>===
=== <font color="green">5:00 PM</font>===
=== <font color="green">5:30 PM</font>===




Line 156: Line 201:


===8:00 AM===
===8:00 AM===
*'''Interviewee:'''  Gregory J. Dehmer, M.D., FSCAI
*'''Confirmed:'''  Y
*'''Topic:'''  PCI and surgical backup
*'''On-site phone:'''  254-721-3657


===8:30 AM===
=== <font color="green">8:30 AM</font>===


===9:00 AM===
===9:00 AM===
*'''Interviewee:''' L. Kristin Newby and Robert Giugliano
*'''Confirmed (Y/N):''' Y
*'''Trial:''' Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndromes (EARLY ACS)
*'''Phone number:''' 617-842-8320 (Dr. Giugliano), 919-612-3305 (Dr. Newby)


===9:30 AM===
=== <font color="green">9:30 AM</font>===


===10:00 AM===
===10:00 AM===
Line 171: Line 224:
*'''Confirmed:'''  Y
*'''Confirmed:'''  Y
*'''Topic:'''  TBD  
*'''Topic:'''  TBD  
*'''On-site phone:'''
*'''On-site phone:''' 917-432-4286


===11:30 AM===
===11:30 AM===
*'''Interviewees: ''' Norm Linsky and Tim Elsner
*'''Confirmed:'''  Y
*'''Topic:'''  Collaboration Between SCAI and Mended Hearts / Mended Little Hearts
*'''On-site phones:'''  202-741-9848 and 214-360-6150


===12:00 PM===
===12:00 PM===
Line 183: Line 240:
===12:30 PM===
===12:30 PM===


===1:00 PM===
=== <font color="green">1:00 PM</font>===


=== <font color="green">1:30 PM</font>===
=== <font color="green">1:30 PM</font>===
Line 195: Line 252:
=== <font color="green">3:30 PM</font>===
=== <font color="green">3:30 PM</font>===


===4:00 PM===
=== <font color="green">4:00 PM</font>===


===4:30 PM===
===4:30 PM===

Latest revision as of 12:19, 29 March 2009

Here is the page we will use to coordinate interviews at ACC 2009

Filming location: Rosen Plaza Hotel 9700 International Drive Phone: 407-996-9700

Filming will occur from Saturday to Tuesday (March 28 - March 31). Dr. Gibson is available to interview during all times listed in black. For all times listed in green, Dr. Gibson is unavailable to conduct the interview. As a presenter, you should go ahead and speak about your topic/present your slides.


Click on Date for Detailed Schedule

Saturday March 28, 2009

Sunday March 29, 2009

Monday March 30, 2009

Tuesday March 31, 2009

Saturday, March 28, 2009

Presentations will occur throughout the day on Saturday. Dr. Gibson will not be available to interview between 2:00 and 5:00 PM. As a presenter you should go ahead and speak about your topic and present your slides during these times (listed in green).

2:00 PM

  • Interviewee: Gilles Montalescot (Slide presentation)
  • Confirmed (Y/N): Y
  • Trial: Immediate Versus Next Day Catheterization in Non-ST Elevation Acute Coronary Syndrome: Results of the Multicenter Randomized ABOARD Study
  • Phone number: +33 6 12592326

2:30 PM

3:00 PM

3:30 PM

4:00 PM

4:30 PM

5:00 PM

Return to top

Sunday March 29, 2009

Presentations will occur throughout the day on Sunday. Dr. Gibson will not be available to interview between 7:00 AM and 11:00 AM, 1:30 PM to 4:00 PM, and 6:00 PM to 9:30 PM. As a presenter you should go ahead and speak about your topic and present your slides during these times (listed in green).

8:00 AM

8:30 AM

9:00 AM

9:30 AM

10:00 AM

10:30 AM

  • Interviewee: Ziyad M. Hijazi, M.D., MPH, FSCAI
  • Confirmed: Y
  • Topic: SCAI's Structural Heart Disease Council and other SCAI initiatives
  • On-site phone: 773-936-8481

11:00 AM

  • Interviewee: Bonnie H. Weiner, M.D., FSCAI
  • Confirmed: Y
  • Topic: TBD
  • On-site phone: 978-501-2158

11:30 AM

  • Interviewee: Andrew J. Boyle, M.D.
  • Confirmed: Y
  • Trial: The VentrAssist U.S. Pivotal Bridge to Cardiac Transplantation Trial
  • On-site phone: 612-578-9149

12:00 PM

  • Interviewee: Chris Cates
  • Confirmed: Y
  • Trial: Acute stroke intervention and neuro-rescue

12:30 PM

1:00 PM

  • Interviewee: Steven R. Bailey, M.D., FSCAI
  • Confirmed: Y
  • Topic: TBD
  • On-site phone: 210-416-3175

1:30 PM

2:00 PM

2:30 PM

3:00 PM

3:30 PM

4:00 PM

  • Interviewee: Ted Feldman, MD, FSCAI,
  • Confirmed: Y
  • Topic: Evalve, SYNTAX, and PFO for stroke + migraine
  • On-site phone:

4:30 PM

  • Interviewee: Davy Cheng
  • Confirmed (Y/N): Y
  • Trial: Endovascular Versus Open Surgical Repair of Thoracic Aortic Disease: A Meta-regression Analysis
  • Phone number: 519-859-0219

5:00 PM

  • Interviewee: Christian Hamm
  • Confirmed (Y/N): Y
  • Trial: Prehospital Tirofiban in ST-Elevation Myocardial Infarction: One-Year Outcome of ON-TIME-2
  • Phone number: + 49 172 69 36 243

Return to top

Monday March 30, 2009

Presentations will occur throughout the day on Monday. Dr. Gibson will not be available to interview between 12:00 and 2:00 PM, 4:30 to 5:30 PM, and 6:00 PM to 9:30 PM. As a presenter you should go ahead and speak about your topic and present your slides during these times (listed in green).

8:00 AM

8:30 AM

  • Interviewee: David Cohen
  • Confirmed: Y
  • Trial: Health Related Quality of Life and U.S. Based Economic Outcomes of PCI With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel and Left Main Coronary Artery Disease: 1-Year Results From the SYNTAX Trial
  • On-site phone: 617-519-0310

9:00 AM

  • Interviewee: Mark Creager
  • Confirmed: Y
  • Trial: Treatment of Intermittent Claudication With Hypoxia-Inducible Factor-1α
  • On-site phone:

9:30 AM

  • Interviewee: Raimund Erbel
  • Confirmed: Y
  • Topic: Signs of Subclinical Coronary Atherosclerosis Measured as Coronary Artery Calcification Improve Risk Prediction of Hard Events Beyond Traditional Risk Factors in an Unselected General Population: The Heinz Nixdorf Recall Study Five-Year Outcome Data
  • On-site phone: 49 173 283 7339

10:00 AM

  • Interviewee: Robert Hendel
  • Confirmed: Y
  • Trial: Multicenter Assessment of the Utilization of SPECT Myocardial Perfusion Imaging Using the ACCF Appropriateness Criteria: The ACCF and United HealthCare SPECT Pilot Study
  • On-site phone: 630-310-2162

10:30 AM

  • Interviewee: Daniel Mark
  • Confirmed: Y
  • Trial: Quality of Life Outcomes With Surgical Ventricular Reconstruction in Symptomatic Heart Failure: Results From the STICH Trial
  • On-site phone:

11:00 AM

  • Interviewee: Germano DiSciascio
  • Confirmed: Y
  • Trial: Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention. Preliminary Results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Randomized Trial
  • On-site phone: +39-335-6157260

11:30 AM

  • Interviewee: Larry S Dean, M.D., FSCAI
  • Topic: Washington State DES coverage decision OR Washington off-site surgery CON process
  • Confirmed: Y
  • On-site phone:

12:00 PM

12:30 PM

1:00 PM

1:30 PM

2:00 PM

2:30 PM

  • Interviewee: Mark Turco, MD, FSCAI
  • Confirmed: Y
  • Topic: Comparative Effectiveness Research
  • On-site phone: 301-938-3485

3:15 PM

  • Interviewee: Tobias Reichlin
  • Confirmed: Y
  • Topic: Incremental Value of Copeptin for Rapid Rule out of Acute Myocardial Infarction
  • On-site phone: 0041 79 755 06 31

4:00 PM

4:30 PM

5:00 PM

Return to top

Tuesday March 31, 2009

Presentations will occur throughout the day on Tuesday. Dr. Gibson will not be available to interview between 1:30 and 3:30 PM. As a presenter you should go ahead and speak about your topic and present your slides during these times (listed in green).

8:00 AM

  • Interviewee: Gregory J. Dehmer, M.D., FSCAI
  • Confirmed: Y
  • Topic: PCI and surgical backup
  • On-site phone: 254-721-3657

8:30 AM

9:00 AM

  • Interviewee: L. Kristin Newby and Robert Giugliano
  • Confirmed (Y/N): Y
  • Trial: Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndromes (EARLY ACS)
  • Phone number: 617-842-8320 (Dr. Giugliano), 919-612-3305 (Dr. Newby)

9:30 AM

10:00 AM

10:30 AM

11:00 AM

  • Interviewee: George Dangas, MD, PhD, FSCAI
  • Confirmed: Y
  • Topic: TBD
  • On-site phone: 917-432-4286

11:30 AM

  • Interviewees: Norm Linsky and Tim Elsner
  • Confirmed: Y
  • Topic: Collaboration Between SCAI and Mended Hearts / Mended Little Hearts
  • On-site phones: 202-741-9848 and 214-360-6150

12:00 PM

  • Interviewee: George Dangas
  • Confirmed (Y/N): Y
  • Trial: Predictors of Stent Thrombosis After Primary Angioplasty in Acute Myocardial Infarction: The HORIZONS-AMI Trial
  • Phone number: 917-432-4286

12:30 PM

1:00 PM

1:30 PM

2:00 PM

2:30 PM

3:00 PM

3:30 PM

4:00 PM

4:30 PM

5:00 PM

5:30 PM

Return to top

Retrieved from "https://www.wikidoc.org/index.php?title=ACC_2009_schedule&oldid=538345"